HALOTEX Drug Patent Profile
✉ Email this page to a colleague
When do Halotex patents expire, and what generic alternatives are available?
Halotex is a drug marketed by Westwood Squibb and is included in two NDAs.
The generic ingredient in HALOTEX is haloprogin. There is one drug master file entry for this compound. Additional details are available on the haloprogin profile page.
Summary for HALOTEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 38 |
Patent Applications: | 3,616 |
DailyMed Link: | HALOTEX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for HALOTEX
US Patents and Regulatory Information for HALOTEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Westwood Squibb | HALOTEX | haloprogin | CREAM;TOPICAL | 016942-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Westwood Squibb | HALOTEX | haloprogin | SOLUTION;TOPICAL | 016943-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |